Stay updated on T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial
Sign up to get notified when there's something new on the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page.

Latest updates to the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedAdded: Revision: v3.4.2; Deleted: Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check18 days agoChange DetectedThis change is a minor revision updating the page from v3.4.0 to v3.4.1 with no visible impact on study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check32 days agoChange DetectedMinor UI and labeling updates: glossary display is now shown by default, a 'Last Update Submitted that Met QC Criteria' indicator was added, the FEAR Act data label capitalization changed, and the page revision updated to v3.4.0 (from v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page now displays Revision: v3.3.4 and no longer shows Revision: v3.3.3.SummaryDifference0.0%

- Check68 days agoChange DetectedAdded a comprehensive Locations section listing trial sites across the US and Canada (and included multiple provinces), reflecting expanded site availability. The previous location sublists and the HHS Vulnerability Disclosure link were removed or updated, accompanying a Revision: v3.3.3.SummaryDifference0.8%

- Check89 days agoChange DetectedRevision tag updated from v3.3.1 to v3.3.2; no user-facing content changes detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page.